Shorter antibiotic course may be just as effective for tough lung infections
NCT ID NCT03477292
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a 7-day course of antibiotics works as well as the standard 14-day course for treating a serious lung infection (ventilator-associated pneumonia) caused by drug-resistant bacteria. The goal was to see if shorter treatment could reduce side effects and help prevent antibiotic resistance. The study involved 41 adults on ventilators who had this specific infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Respiratory ICU, Department of Pulmonary Medicine, PGIMER
Chandigarh, Chandigarh, 160012, India
-
Respiratory ICU, Post Graduate Institue of Medical Education and Research
Chandigarh, Chandigarh, 160012, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Speedier lab test could curb superbug threat in ICU pneumonia
- Human milk mouth care may shield preemies from lung infections
- Could a 'robotic cough' stop deadly pneumonia in ICU patients?
- Can a simple inhaled antibiotic stop deadly pneumonia in ventilator patients?
- AI reads chest X-Rays to spot deadly ICU lung infections
- Hospital study reveals key risk factors for superbug pneumonia